Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis

The unprecedented successes of immunotherapies (IOs) including immune checkpoint blockers (ICBs) and adoptive T-cell therapy (ACT) in patients with late-stage cancer provide proof-of-principle evidence that harnessing the immune system, in particular T cells, can be an effective approach to eradicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Lewis Zhichang, Bonner, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619591/
https://www.ncbi.nlm.nih.gov/pubmed/34830176
http://dx.doi.org/10.3390/ijms222212295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619591/
https://www.ncbi.nlm.nih.gov/pubmed/34830176
http://dx.doi.org/10.3390/ijms222212295

Ejemplares similares